Flonase Related Published Studies
Well-designed clinical trials related to Flonase (Fluticasone Nasal)
Efficacy, dose reduction, and resistance to high-dose fluticasone in patients
with eosinophilic esophagitis. [2014]
Fluticasone impact on airway dendritic cells in smokers: a randomized controlled
trial. [2013]
An integrated analysis of the efficacy of fluticasone furoate nasal spray versus
placebo on the nasal symptoms of perennial allergic rhinitis. [2013]
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and
fluticasone propionate) in the treatment of seasonal allergic rhinitis: a
randomized, double-blind, placebo-controlled trial of efficacy and safety. [2012]
Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial. [2011.10.06]
Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. [2011.09]
[Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children]. [2011.07]
Long-term monotherapy with suplatast tosilate in patients with mild atopic asthma: a pilot comparison with low-dose inhaled fluticasone. [2011.06]
Effect of fluticasone furoate on interleukin 6 secretion from adenoid tissues in children with obstructive sleep apnea. [2011.06]
Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. [2011.05]
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. [2011.04]
Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers. [2011.04]
Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone. [2011.03]
Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control. [2011.02]
Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial. [2011.01]
Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease. [2011.01]
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment
of perennial allergic rhinitis. [2011]
Comparison of heat-sensitive moxibustion versus fluticasone/salmeterol (seretide) combination in the treatment of chronic persistent asthma: design of a multicenter randomized controlled trial. [2010.12.15]
Difference between patient-reported side effects of ciclesonide versus fluticasone propionate. [2010.12]
Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma. [2010.12]
Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. [2010.11.15]
Fluticasone furoate nasal spray is effective and well tolerated for perennial allergic rhinitis in adolescents and adults. [2010.11]
The effect of inhaled salmeterol, alone and in combination with fluticasone propionate, on management of COPD patients. [2010.10]
Montelukast added to fluticasone propionate does not alter inflammation or outcomes. [2010.10]
Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone. [2010.09.07]
Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis. [2010.09.01]
Quality of life is improved by endoscopic surgery and fluticasone in nasal polyposis with asthma. [2010.09]
Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma. [2010.09]
Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. [2010.08]
Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis. [2010.08]
Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma. [2010.08]
A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma. [2010.08]
Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion. [2010.07.01]
Salmeterol/fluticasone treatment reduces circulating C-reactive protein level in patients with stable chronic obstructive pulmonary disease. [2010.07]
Medical treatment of adenoid hypertrophy with "fluticasone propionate nasal drops". [2010.07]
Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children. [2010.06]
Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer. [2010.06]
Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. [2010.05]
Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. [2010.04.01]
Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study. [2010.04]
Low-dose fluticasone propionate with and without salmeterol in steroid-naive patients with mild, uncontrolled asthma. [2010.04]
Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma. [2010.03]
Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma. [2010.03]
Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment. [2010.03]
Effects of budesonide and fluticasone propionate in pediatric asthma patients. [2010.02]
Effect of fluticasone on markers of inflammation and quality of life in steroid-naive patients with mild asthma. [2010.01]
Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. [2010.01]
Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. [2010]
Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study. [2010]
An integrated analysis of the efficacy of fluticasone furoate nasal spray on
individual nasal and ocular symptoms of seasonal allergic rhinitis. [2010]
Quality of life is improved by endoscopic surgery and fluticasone in nasal
polyposis with asthma. [2010]
Double-blind, placebo-controlled study of azelastine and fluticasone in a single
nasal spray delivery device. [2010]
Effect of the addition of montelukast to fluticasone propionate for the treatment
of perennial allergic rhinitis. [2010]
Comparison of patient preference for sensory attributes of fluticasone furoate or
fluticasone propionate in adults with seasonal allergic rhinitis: a randomized,
placebo-controlled, double-blind study. [2010]
Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound
congestion. [2010]
Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and
fluticasone propionate in patients with persistent asthma. [2010]
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol
versus montelukast. [2010]
Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with
moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind
non-inferiority trial vs. fluticasone 0.005% ointment. [2010]
Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device. [2009.12]
Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study. [2009.12]
Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED). [2009.11]
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. [2009.10.31]
Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. [2009.10.20]
Add-on salmeterol compared to double dose fluticasone in pediatric asthma: A double-blind, randomized trial (VIAPAED). [2009.10.12]
Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes. [2009.10]
Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma. [2009.10]
Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma. [2009.09]
A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination. [2009.08]
Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. [2009.08]
Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. [2009.08]
Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial. [2009.07]
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. [2009.06.30]
Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis. [2009.06.18]
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. [2009.06]
Long-term study of fluticasone propionate aqueous nasal spray in acute and maintenance therapy of nasal polyposis. [2009.06]
Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. [2009.06]
Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. [2009.06]
Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. [2009.06]
Effectiveness of fluticasone furoate 110 mug once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen * [2009.05.06]
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. [2009.05]
Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. [2009.05]
HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis. [2009.05]
Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. [2009.05]
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone. [2009.04]
Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. [2009.04]
Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. [2009.04]
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. [2009.03]
Effect of inhaled fluticasone on lung function in infants with recurrent wheezing: a randomised controlled trial. [2009.03]
Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone. [2009.03]
In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler. [2009.02]
Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. [2009.01.22]
Comparative safety and efficacy of 2 formulations of fluticasone aqueous nasal spray in persistent allergic rhinitis. [2009.01]
Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis. [2009.01]
Comparison of the clinical efficacy and safety of salmeterol/fluticasone propionate versus current care in the management of persistent asthma in Korea. [2008.12]
Dose-ranging study of fluticasone furoate nasal spray for Japanese patients with perennial allergic rhinitis*. [2008.12]
Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related. [2008.11]
A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis. [2008.11]
Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics. [2008.11]
Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. [2008.10]
Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down". [2008.10]
Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. [2008.09]
|
